Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.
about
Androgen receptor auto-regulates its expression by a negative feedback loop through upregulation of IFI16 proteinMolecular pathology of prostate cancerIntracellular calcium dynamics during photolysis.Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma.Target sites for manipulating apoptosis in prostate cancer.Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.Mouse models of prostate cancer: picking the best model for the question.Tailoring to RB: tumour suppressor status and therapeutic response.miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrestHuman prostate cancer risk factors.Analysis of candidate genes has proposed the role of y chromosome in human prostate cancer.Current status of the molecular genetics of human prostatic adenocarcinomas.Molecular aspects of diagnostic nucleolar and nuclear envelope changes in prostate cancer.Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradationSurvey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.Targeting prostate cancer based on signal transduction and cell cycle pathways.Genomic signatures associated with the development, progression, and outcome of prostate cancer.Time to stratify? The retinoblastoma protein in castrate-resistant prostate cancer.Molecular pathways in prostate cancer.NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells.p16 mutations/deletions are not frequent events in prostate cancerRole of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells.Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors.Alterations of the retinoblastoma gene in human prostate adenocarcinoma.Tumour-suppressor genes in prostatic oncogenesis: a positional approach.Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen.Diagnostic and prognostic markers for human prostate cancer.Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers.BPH gene expression profile associated to prostate gland volumeNUSAP1 promotes invasion and metastasis of prostate cancerRegulation of cell proliferation in a stratified culture system of epithelial cells from prostate tissue.Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.Is PTEN loss associated with clinical outcome measures in human prostate cancer?Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade.Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells.The Genomics of Prostate Cancer: emerging understanding with technologic advances.
P2860
Q24305403-BD774E23-3B27-43BC-9FB3-C99A32E64691Q24672410-F1A931E7-4399-4B44-8604-583776D64CDDQ30643148-E6698C08-2790-4511-9BB9-C7CC1E38C878Q33867671-6B16C886-1447-4A24-9229-B863BA6C20FBQ33898831-D4DCF283-5DBD-46F1-B1BC-23A63425AE97Q33926909-A2258645-B508-46DC-A90A-5D56E3A4966FQ33940867-58B7FC05-9876-4276-8D64-775D40AC8405Q34040108-F9DAEAF9-7171-4269-9E55-103070541FBCQ34189798-270BF26E-762E-419A-BD45-F710574BD81BQ34253178-C525DCE7-DA49-4F15-B08E-B98AEF7F6AC5Q34360616-3BF1705A-40B2-4959-9A35-45FE40E5373BQ35015903-9412F4DB-11CC-481C-BAA6-87912E9F0B86Q35019942-04B377F5-1197-4BC6-9AE1-F374F9CD6113Q35613248-E0A7C1F6-F709-450E-ADD3-CA5E552BA7BDQ35798342-96914946-B2A7-412C-B6CA-7291E401054AQ35835242-80DFB102-409E-4F64-B58E-348657972BF1Q35964278-72E3EF8F-0A7A-4192-89EE-0E03E217D0C0Q36995054-3E5AAF21-E0EB-4E43-B6F1-C7A46435401EQ37031510-4A23A1BC-5A3E-4586-BDF0-F8EE89194554Q37910715-D1B12870-4D7E-4C05-A05E-7C267CB06880Q38166735-7E7F0F49-4048-4A31-B487-6E2079DBF1F6Q38920403-A2D2346D-E9C5-490D-836F-2C366A288869Q39996357-C77E4E53-50A4-4D9D-8EA9-63FAFC852512Q40243680-4A4C2441-7957-40AD-981D-16AE76616D71Q41046879-2D085A79-5C24-4663-AA9D-0C6AA9B40E7AQ41231236-ECE8A17F-BD9D-4821-AF02-EB245BB46B83Q41409406-FB3CDD00-BDD8-4B90-8266-C69C4B50860DQ41409603-286687F8-F069-4B1A-8C70-E05EC51F7ADBQ41495930-B48479F2-45A0-4B73-92C2-6A4FCA072F9BQ41734202-DED9BBAF-AC16-487A-8B85-43B802B111CAQ42103664-893D200B-F97F-41FE-81DD-5FF2D5853368Q42244850-3A50CA91-27E4-4302-9A8A-54DF5CA371ACQ42492547-6A75F704-2DFB-455B-AA7C-80E7E8ECD531Q42855019-5A15218B-261A-4DB9-ACE5-E40099F6930DQ43249619-A6793CB9-85AE-4FE5-B133-FB676628D366Q44472432-F52C17FB-5D73-4E0A-85D9-D9564874155CQ46120492-F6F7ACE9-3B74-49CC-9EC8-E6EE8D7E2768Q47158122-2F991190-A5AA-4F92-AA7A-53D8B4FEC2CBQ47761529-A7B10817-AC9B-44A8-B5AE-02BAE0A945AFQ48317607-6AE6C6C1-ED9D-4C6C-BD8E-6498E2424AEF
P2860
Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Loss of the retinoblastoma sus ...... nt in prostatic tumorigenesis.
@ast
Loss of the retinoblastoma sus ...... nt in prostatic tumorigenesis.
@en
Loss of the retinoblastoma susceptibility gene
@nl
type
label
Loss of the retinoblastoma sus ...... nt in prostatic tumorigenesis.
@ast
Loss of the retinoblastoma sus ...... nt in prostatic tumorigenesis.
@en
Loss of the retinoblastoma susceptibility gene
@nl
prefLabel
Loss of the retinoblastoma sus ...... nt in prostatic tumorigenesis.
@ast
Loss of the retinoblastoma sus ...... nt in prostatic tumorigenesis.
@en
Loss of the retinoblastoma susceptibility gene
@nl
P2093
P2860
P356
P1476
Loss of the retinoblastoma sus ...... ent in prostatic tumorigenesis
@en
P2093
C M Barton
D G Morton
D M Wallace
N R Lemoine
S M Phillips
P2860
P2888
P304
P356
10.1038/BJC.1994.482
P407
P577
1994-12-01T00:00:00Z
P5875
P6179
1046776551